David L. Fischel - 20 May 2021 Form 4 Insider Report for Stereotaxis, Inc. (STXS)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
20 May 2021, 16:15:40 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kimberly R. Peery, Attorney-in-Fact, for David L. Fischel

Key filing fact

David L. Fischel filed Form 4 for Stereotaxis, Inc. (STXS) on 20 May 2021.

Key facts

  • This page summarizes David L. Fischel's Form 4 filing for Stereotaxis, Inc. (STXS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 20 May 2021, 16:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STXS transaction Derivative

Performance share units

Award

Transaction value
$0
Shares
+13,000,000
Change %
Price
$0.000000
Shares after
13,000,000
Date
20 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,000,000
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each performance share unit represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

On February 23, 2021, the Issuer's board of directors, based upon the recommendation of the Compensation Committee, granted the reporting person a performance share unit award of up to 13,000,000 shares of common stock (the "Award"), subject to stockholder approval of the issuance of the shares under the Award. The Issuer's stockholders approved the issuance of the shares under the Award on May 20, 2021.

Footnote F3

The Award consists of ten tranches which vest based on the attainment of market capitalization milestones, and subject to the reporting person continuing to serve as the Chief Executive Officer, Executive Chairman or such other mutually agreed upon significant role with the Issuer from the grant date through December 31, 2030, all subject to the exceptions set forth in the Award agreement. The market capitalization milestones are subject to adjustment following certain acquisitions and spin-off transactions by the Issuer, and the number of shares subject to the Award shall be adjusted following stock splits, stock dividends, combinations or reclassifications of shares, recapitalization, consolidation, split-up, merger, or similar transactions. The service component of the award will be waived upon the occurrence of certain events in set forth in the Award agreement. The Award agreement has been filed as an exhibit to the Company's filings with the Securities and Exchange Commission.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .